Key points are not available for this paper at this time.
What We're Reading| March 04 2024 A Sampling of Highlights from the Literature: Article Recommendations from Our Deputy and Senior Editors Author 12 (3): 281. https://doi.org/10.1158/2326-6066.CIR-12-3-WWR Download citation file: Ris (Zotero) Reference Manager EasyBib Bookends Mendeley Papers EndNote RefWorks BibTex toolbar search Search Dropdown Menu toolbar search search input Search input auto suggest Search Advanced Search Research identifies epigenetic and transcriptomic regulators of stemlike CD8+ CAR T-cell fate (Klem via Wikimedia Commons) How stemlike CD8+ chimeric antigen receptor (CAR) T-cell (Ts) differentiation to effector-like CD8+ CAR T cells (Teff) or terminally exhausted CD8+ CAR T cells (Tex) is regulated is not well understood. Through single-cell transcriptomic and epigenomic analyses, Zhu et al. show that each of these three CD8+ CAR T-cell subsets are defined by distinct transcription factors. Changes in chromatin accessibility precede transcriptional changes, priming a cell for regulation by the next set of transcription factors. FOXP1 limits Ts to Teff differentiation, whereas KLF2 promotes Teff differentiation and suppresses Tex differentiation. The data may provide new ways to manipulate CD8+ CAR T-cell differentiation for therapeutic benefit. Zhu Z, …, Wu T. Nat Immunol 2023 November 27;25:117–28. Pancreatic cancer... You do not currently have access to this content.
Building similarity graph...
Analyzing shared references across papers
Loading...
A Mon, study studied this question.
www.synapsesocial.com/papers/68e75ca9b6db6435876d432c — DOI: https://doi.org/10.1158/2326-6066.cir-12-3-wwr
Cancer Immunology Research
Building similarity graph...
Analyzing shared references across papers
Loading...